Bellicum Is Worth A Look With Multiple Catalysts On The Way In 2nd Half Of 2019
September 05, 2019 at 09:46 AM EDT
Bellicum is a highly undervalued biotech. Especially, when you consider that it has two types of technology that can be utilized to potentially alter how CAR-T therapies are produced.
